The cell-penetrating peptide octa-arginine is a potent inhibitor of proteasome activities

Oligo-arginines are cell-penetrating peptides and find use as carriers for transportation of various membrane-impermeable biopharmaceuticals into target cells. We have found that oligo-arginines of a length of 4–10 amino acids, but especially (Arg) 8, are able to inhibit the major intracellular prot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmaceutics and biopharmaceutics 2009-05, Vol.72 (1), p.219-225
Hauptverfasser: Kloß, Alexander, Henklein, Peter, Siele, Dagmar, Schmolke, Marion, Apcher, Sébastien, Kuehn, Lothar, Sheppard, Paul W., Dahlmann, Burkhardt
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Oligo-arginines are cell-penetrating peptides and find use as carriers for transportation of various membrane-impermeable biopharmaceuticals into target cells. We have found that oligo-arginines of a length of 4–10 amino acids, but especially (Arg) 8, are able to inhibit the major intracellular proteolytic system, the proteasome, with mixed-type inhibition characteristics. The IC 50 values of (Arg) 8 for the proteasomal chymotrypsin-like and caspase-like activities are approximately 100 and 200 nM, respectively. The inhibition of the trypsin-like activity never exceeds 50% even at micromolar concentrations. (Arg) 8 also inhibits 20S proteasome/PA28 complexes as well as 26S proteasomes, although with a decreased efficiency. Due to its cell membrane-penetrating capability, incubation of HeLa cells in the presence of (Arg) 8 resulted in an impaired activity of proteasomes going along with an accumulation of high-molecular mass ubiquitin-conjugated proteins, the preferred substrates of 26S proteasomes. The in vivo susceptibility of the three proteasome activities resembles that found in vitro with chymotrypsin-like > caspase-like > trypsin-like activities. Since inhibition of the proteasome system might affect fundamental basic cellular processes but on the other side might also prevent the degradation of a proteinacous cargo, we suggest that this proteasome inhibitory activity should be taken into account when oligo-arginines are being considered for use as vectors for the intracellular delivery of pharmaceuticals.
ISSN:0939-6411
1873-3441
DOI:10.1016/j.ejpb.2008.10.016